dc.contributor.author |
Borrmann, Steffen |
|
dc.contributor.author |
Grobusch, Martin |
|
dc.date.accessioned |
2023-05-22T14:43:54Z |
|
dc.date.available |
2023-05-22T14:43:54Z |
|
dc.date.issued |
2023 |
|
dc.identifier.issn |
1477-8939 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/141321 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Elsevier Sci Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.tmaid.2022.102520 |
de_DE |
dc.subject.ddc |
300 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20230202000000_00083 |
|
utue.personen.roh |
Schnyder, Jenny L. |
|
utue.personen.roh |
Jong, Hanna K. de |
|
utue.personen.roh |
Bache, Emmanuel B. |
|
utue.personen.roh |
Hest, Reinier M. van |
|
utue.personen.roh |
Schlagenhauf, Patricia |
|
utue.personen.roh |
Borrmann, Steffen |
|
utue.personen.roh |
Hanscheid, Thomas |
|
utue.personen.roh |
Grobusch, Martin P. |
|
dcterms.isPartOf.ZSTitelID |
Travel Medicine and Infectious Disease |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 102520 |
de_DE |
dcterms.isPartOf.ZS-Volume |
52 |
de_DE |